Chen GQ,Shi XG,Tang W,et al. Use of arsenic trioxide in the treatment of acute promyelocytic leukemia:Ⅰ. As2O3 exerts dose-dependent dual effets on APL cells[J]. Blood, 1997, 89: 3345-3353.
[7]
Chen GQ,Zhu J,Shi XG. In vitro studies on cellular and molecular mechanisms of arsenic trioxide in the treatment of acute promyelocytic leukemia:As2O3 induces NB4 cell apoptosis with downregulation of bcl-2 expresion and modulation of PML-RAR alpha/PML proteins [J]. Blood,1996,88:1052-1061.
[8]
Chen Z,Chen GQ,Shen ZX,et al. Treatment of acute promyelocytic leukemia with arsenic compounds:in vitro and in vivo studies[J]. Semin Hematol,2001,38(1):26-36.
[9]
Wang ZY,Chen Z. Differentiation and apoptosis induction therapy in acute promye- locytic leukaemia[J]. Lancet Oncol,2001,1:101-106.